TrialArthritis research & therapy2014

Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients.

Michael S Hershfield et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.